Sign In
Buy ASND
$243.91
-7.16 (-2.85%)
At Close: Jul 31, 2026
Altra Industrial Motion Corp (AIMC) Q2 2020 Earnings Call Transcript | The Motley Fool
08:30pm, Friday, 24'th Jul 2020
AIMC earnings call for the period ending June 30, 2020.
Why Ascendis Pharma (ASND) Stock is a Compelling Investment Case
01:47pm, Friday, 24'th Jul 2020
Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Mid-Cap Growth Fund posted a return of 31.64% for the quarter, outperforming its benchmark, the
Altra Industrial Motion Corp. : Announces Third Quarter 2020 Dividend | MarketScreener
04:57pm, Wednesday, 22'nd Jul 2020Vident Investment Advisory LLC Buys New Shares in Ascendis Pharma A/S (NASDAQ:ASND)
06:22am, Wednesday, 22'nd Jul 2020
Vident Investment Advisory LLC purchased a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Co
Ascendis Pharma A/S (NASDAQ:ASND) Lowered to Sell at Zacks Investment Research
05:26am, Tuesday, 14'th Jul 2020
Zacks Investment Research cut shares of Ascendis Pharma A/S (NASDAQ:ASND) from a hold rating to a sell rating in a research report released on Monday morning, Zacks.com reports. According to Zacks, �
Did Hedge Funds Make The Right Call On Ascendis Pharma A/S (ASND) ?
12:49am, Saturday, 11'th Jul 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
02:11am, Wednesday, 08'th Jul 2020
Ascendis Pharma A/S (ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced the pricing of its underwritten public off
Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
12:00am, Wednesday, 08'th Jul 2020
COPENHAGEN, Denmark, July 07, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative...
Ascendis Pharma A/S Announces Proposed Public Offering of ADSs
04:58pm, Monday, 06'th Jul 2020
Ascendis Pharma A/S (ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced that it has commenced an underwritten publ
Ascendis Pharma A/S (ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced that it received a positive opinion from the
Ascendis Pharma A/S Announces Proposed Public Offering of ADSs
12:00am, Monday, 06'th Jul 2020
COPENHAGEN, Denmark, July 06, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative...
Alexion's European Approval And Other News: The Good, Bad And Ugly Of Biopharma
03:45am, Tuesday, 30'th Jun 2020
Alexion's Ultomiris is approved in Europe. Intercept suffers a setback. Ascendis applies for label expansion of TransCon.
Wedbush Initiates Coverage on Ascendis Pharma A/S (NASDAQ:ASND)
02:50am, Tuesday, 30'th Jun 2020
Wedbush assumed coverage on shares of Ascendis Pharma A/S (NASDAQ:ASND) in a research note issued to investors on Friday morning, AnalystRatings.com reports. The firm issued a buy rating and a $188.00
Ascendis Submits BLA to FDA for TransConhGH in Pediatric GHD
03:44pm, Monday, 29'th Jun 2020
Ascendis Pharma (ASND) submits BLA to the FDA for TransConhGH for the treatment of pediatric growth hormone deficiency.
